Propanc Biopharma, Inc.
General ticker "PPCB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $21.6M (TTM average)
Propanc Biopharma, Inc. does not follow the US Stock Market performance with the rate: -22.0%.
Estimated limits based on current volatility of 9.0%: low 0.78$, high 0.93$
Factors to consider:
- Total employees count: 2 (0.0%) as of 2024
- Top business risk factors: Regulatory and compliance, Capital raising, Execution of business plan, Lack of diversification, Market volatility
Short-term PPCB quotes
Long-term PPCB plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.78MM | $1.54MM | $57.28MM |
| Operating Income | $-1.78MM | $-1.54MM | $-57.28MM |
| Non-Operating Income | $-1.01MM | $-0.41MM | $-1.65MM |
| Interest Expense | $0.53MM | $0.67MM | $0.56MM |
| R&D Expense | $0.25MM | $0.25MM | $0.22MM |
| Income(Loss) | $-2.79MM | $-1.95MM | $-58.92MM |
| Taxes | $-0.13MM | $-0.13MM | $0.00MM |
| Profit(Loss)* | $-2.66MM | $-1.82MM | $-58.92MM |
| Stockholders Equity | $-3.12MM | $-3.78MM | $13.91MM |
| Assets | $0.06MM | $0.07MM | $19.63MM |
| Operating Cash Flow | $-1.11MM | $-0.94MM | $-0.41MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $1.11MM | $0.94MM | $0.49MM |
| Earnings Per Share** | $-26,605.66 | $-1,285.11 | $-14.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.